Project Grant R01EB036854
- The National Institute of Allergy and Infectious Diseases awarded Louisiana State University Health Sciences Center New Orleans $225,000 on August 18, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to develop and evaluate hydrogel-forming covalent conjugates of caprylic acid as therapeutics for infected wounds. The research aims to engineer self-assembling gel-forming conjugates that covalently link caprylic acid with tripeptides to overcome rapid clearance and...
- This $377,932 federal Project Grant award, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research by Louisiana State University Health Sciences Center New Orleans to develop innovative techniques for dispersing bacterial biofilms on bones and medical hardware. The research aims to improve the treatment of bone fractures and infections, with a focus on advancing enzymatic debridement approaches. The award period runs from...
- The National Institute of Biomedical Imaging and Bioengineering awarded Louisiana State University $143,201 on April 14, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to develop an implantable, stent-based sensor system for continuous monitoring of mechanical biomarkers in arterial disease. The project addresses the absence of technology for daily monitoring of arterial stiffness and viscoelasticity as predictors of...
- The National Institute of Allergy and Infectious Diseases awarded Brown University $542,599 on July 6, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to develop bacteria-responsive hydrogel wound dressings for on-demand delivery of antibiotics and probiotics targeting chronic wound infections caused by methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa. The project addresses antibiotic resistance and biofilm formation in chronic wounds by...
- The National Institute of Allergy and Infectious Diseases awarded Louisiana State University $599,480 on June 10, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to investigate the regulation of neutrophil endoplasmic reticulum stress response by IRE1A in bacterial lung infection. The research addresses innate immune mechanisms that defend against methicillin-resistant Staphylococcus aureus (MRSA) lung infection, a drug-resistant pathogen causing mortality rates up...
- The National Institute of General Medical Sciences awarded the Board of Regents of the University of Nebraska, through its University of Nebraska Medical Center division, $415,113 under the Biomedical Research and Research Training program (CFDA 93.859) on September 1, 2026. The award funds development of nanofiber-based sutures and dressings to reduce surgical site infections, treat wound biofilms, and promote chronic wound healing. The research builds on prior findings demonstrating successful...
- The National Institute of General Medical Sciences (part of the National Institutes of Health, Department of Health and Human Services) awarded $393,800 to the Terasaki Institute for Biomedical Innovation on September 5, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to develop immunomodulatory nanofibrous modular aerogels for chronic wound healing. The research addresses chronic wounds affecting approximately 6.5 million Americans by combining three engineered...
- The National Institute of Biomedical Imaging and Bioengineering awarded Lehigh University $616,375 on April 14, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to develop protease-responsive hydrogels that create cell-specific microenvironments within tissue-engineering matrices. The research addresses the challenge that different cell types within tissues require distinct matrix properties—endothelial cells optimize in...
- Federal Grant Award Summary The University of Nebraska Medical Center (UNMC) received a $435,372 Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), effective August 13, 2025, with a completion date of July 31, 2027. The award funds development of a novel electrotaxis system designed to enhance chronic wound healing by leveraging...
- The National Institute of General Medical Sciences awarded $451,000 to The University of Texas MD Anderson Cancer Center on September 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to dissect the role of extracellular vesicles and matrix in wound healing. The research identifies mechanisms by which fibroblasts respond to tissue injury through extracellular vesicle cargo packaging and extracellular matrix remodeling. The project uses genetically engineered...
The National Institute of Biomedical Imaging and Bioengineering awarded Louisiana State University Health Sciences Center New Orleans $423,201 on August 14, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to design, synthesize, and validate regenerative, immunorestorative, and antimicrobial skin matrices (RIAMS) for infected hard-to-heal wounds in diabetic patients. The research addresses multidrug-resistant bacterial pathogens and combines wound healing, immune restoration, and infection eradication in a single treatment modality by engineering flowable hydrogel scaffolds that deliver bioactive compounds derived from royal jelly and medical-grade honey with sustained release kinetics and controlled viscoelasticity. The award carries a period of performance through July 31, 2030, with work performed in New Orleans, Louisiana. As a Project Grant, the assistance type supports hypothesis- and technology-driven research related to discovery, design, development, validation, and application of biomedical imaging and bioengineering technologies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $423.2k | 8/14/26 |